Publication Date:
Tue, 2011-07-19 09:26
The report filed Monday with the US District Court in Trenton, New Jersey, also recommends the creation of a new board committee to oversee the company’s health care and quality compliance issues.
The findings have been approved unanimously by Johnson & Johnson’s board.
The case was filed last year by shareholders against current and past members of its board of directors and management.
The plaintiffs claimed Johnson & Johnson breached its fiduciary duty as a result of a spate of kickback charges, product recalls and other problems.
Taxonomy upgrade extras:
